9 Meters Biopharm

-$0.03 (-2.33%) Today
+$0.02 (+1.59%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NMTR and other ETFs, options, and stocks.

About NMTR

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs.

CEO
John Temperato
Employees
12
Headquarters
Raleigh, North Carolina
Founded
2012

NMTR Key Statistics

Market Cap
320.99M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.59M
High Today
$1.29
Low Today
$1.25
Open Price
$1.27
Volume
891.83K
52 Week High
$2.26
52 Week Low
$0.63

NMTR Earnings

-$0.57
-$0.38
-$0.19
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 15, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure